NeoGenomics: NeoGenomics, Inc.: NeoGenomics to Host Investor Day on April 4, 2023
FT. MYERS, FL / ACCESSWIRE / March 27, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that the Company will hos...
Read full article »
NeoGenomics is a Florida-based clinical laboratory that provides services including oncology genetic testing, contract research and drug development for physicians.
Read more